LivaNova PLCLIVNEarnings & Financial Report
LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".
LIVN Q3 2025 Key Financial Metrics
Revenue
$357.8M
Gross Profit
$244.9M
Operating Profit
$54.0M
Net Profit
$26.8M
Gross Margin
68.4%
Operating Margin
15.1%
Net Margin
7.5%
YoY Growth
12.5%
EPS
$0.49
Financial Flow
LivaNova PLC Q3 2025 Financial Summary
LivaNova PLC reported revenue of $357.8M for Q3 2025, with a net profit of $26.8M (7.5% margin). Cost of goods sold was $112.9M, operating expenses totaled $190.8M.
Key Financial Metrics
| Total Revenue | $357.8M |
|---|---|
| Net Profit | $26.8M |
| Gross Margin | 68.4% |
| Operating Margin | 15.1% |
| Report Period | Q3 2025 |
LivaNova PLC Annual Revenue by Year
LivaNova PLC annual revenue history includes year-by-year totals (for example, 2024 revenue was $1.3B).
| Year | Annual Revenue |
|---|---|
| 2024 | $1.3B |
| 2023 | $1.2B |
| 2022 | $1.0B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $310.1M | $294.9M | $318.6M | $318.1M | $321.8M | $316.9M | $352.5M | $357.8M |
| YoY Growth | 12.8% | 12.0% | 8.4% | 11.2% | 3.8% | 7.4% | 10.7% | 12.5% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.43B | $2.46B | $2.45B | $2.52B | $2.51B | $2.56B | $2.51B | $2.56B |
| Liabilities | $1.15B | $1.24B | $1.21B | $1.21B | $1.19B | $1.52B | $1.38B | $1.40B |
| Equity | $1.28B | $1.22B | $1.24B | $1.31B | $1.32B | $1.03B | $1.12B | $1.16B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $54.0M | $10.0M | $43.4M | $51.0M | $78.7M | $24.0M | $62.9M | $85.1M |